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time constant of isovolumic relaxation (TAU) on diastolic filling parameters
by radionuclide angiography (RNA) in man are unknown. Therefore, 8 atri-
ally paced patients without coronary artery disease underwent simultane-
ous RNA with micromanometer measurements of left atrial (LA) pressure,
left ventricular (LV) pressure and TAU during baseline and steady-state infu-
sions of nitroprusside (NIP). dobutamine (DOB), and phenylephrine (PHENI.
RNA was acquired in 32 frames and Fourier fitted to obtain peak filling rate
(PFR) and non-normalized PFR (NNPFR). Results below are % change (L'I.%)
from baseline (± SO). 11008-81
Radiofrequency Catheter Ablation
Complex Anatomical Substrates of Right-sided
Accessory Fibers with Mahaim-Type Preexcitation
NIPIL'I.%) DOB ("'%) PHEN ("'%1
TAU 4± 11 -18± 7' 11 ± 12'
LA pressure -25 ± 13' -12 ± 11' 52 ± 35'
AVG -27 ± 18' -12 ± 29 82 ± 53'
PFR -8± 7' -14 ± 12' 5± 11
NNPFR -28± 9' -21 ± 19' 29 ± 29'
'p < 005
Despite an augmented active relaxation with DOB, peak filling rate de-
creased significantly in response to decreased LA pressure. We conclude
the RNA diastolic filling indices are critically dependent on the LA compo-
nent of the AVG.
Michael D. Gammage, Gordon WK. Ching, Terence Stallard, Jackie Daykin, Jayne
A. Franklyn. University ot Birmingham, Birmingham, UK
Thyrotoxicosis results in a number of effects on the cardiovascular system
including changes in blood pressure, peripheral vascular resistance and left
ventricular mass. Whilst many of these are well documented, the reversibil-
ity of these changes with restoration of euthyroidism is less clear and may
have prognostic implications. In addition, patients who have undergone thy-
roidectomy for thyroid carcinoma require chronic high-dose thyroid hormone
therapy; the cardiovascular effects of this therapy have not been assessed
with regard to long term risk. We studied 23 female patients with Graves'
hyperthyroidism (group 1) with no prior history of heart disease at presen-
tation and after 1 and 2 months of carbimazole treatment and 11 female
patients receiving doses of thyroxine sufficient to suppress thyroid stimulat-
ing hormone (TSH) to below normal values (group 2); data were compared
to those from 25 normal female age matched controls. Cardiac dimensions
and function were assessed by 2-dimensional and M-mode echocardiogra-
phy, 24 hour blood pressure and heart rate by automatic ambulatory sphyg-
momanometer. At presentation, group 1 showed increases in mean 24 hour
systolic blood pressure (124 ± 12.4 v 110 ± 6.7 mmHg, p < 0.05) (mean
± SO). mean 24 hour heart rate (99.0 ± 14.4 v 77.0 ± 9.4/min, p < 0.001)
and left ventricular mass index (LVMI) (93.1 ± 12.2 v 78.9 ± 9.0 g/m2, p <
0.03) compared to controls. Fractional shortening (FS) and ejection fraction
(EF) were increased (FS: 39.7 ± 2.1 v 35.8 ± 1.9%, P < 0.05) (EF: 69.8 ±
1.3 v 65.7 ± 1.5%, P < 0.05). All of these indices had returned to normal,
however, after 2 months of carbimazole treatment. In group 2, the only ab-
normality was a significant increase in LVMI compared to controls (100.3 ±
25.9 v 78.9 ± 9.0 g/m2 p < 0.05). Diurnal variation in systolic and diastolic
blood pressure and heart rate were normal in both groups. There were no
changes in either group in assessments of sympathetic activity (tilt testing,
isometric forearm exercise, cold pressor test and Valsalva ratio) or in 24 hour
urinary catecholamines compared with controls, or between presentation
and 2 months in group 1.
Conclusion: The cardiovascular effects of thyrotoxicosis are reversed
rapidly in response to antithyroid treatment with carbimazole; despite the
similarities between thyrotoxicosis and a hyperadrenergic state, our data
show no objective evidence to suggest sympathetic overactivity. Patients re-
ceiving suppressive doses of thyroid hormones show evidence of increased
left ventricular mass; this finding warrants long-term follow up to assess
prognostic implications in terms of future cardiovascular risk.
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Accessory pathways lAPs) with Mahaim-like preexcitation most commonly
have an atrial rather than a nodal origin and terminate in the right ventric-
ular free wall or in the proximity of the right bundle fascicles. Out of 14
consecutive pts undergoing radiofrequency (RF) current ablation of such a
fiber, 2 presented patterns consistent with an atypical anatomical course.
In these pts, endocardial potentials suggestive of AP activation were con-
sistently recorded both at the anterolateral and the posterolateral tricuspid
annuls (TA). In 1 pt, the A-AP interval at the anterolateral TA was shorter, and
the AN amplitude ratio higher, than at the posterolateral TA. At both sites,
progressively premature atrial extrastimulation revealed A-AP prolongation
(decremental conduction). Catheter manipulation at the atrial aspect of the
TA did not produce mechanical block of AP conduction in the anterolateral
region, but RF current applied in this region during atrial pacing transiently
and repeatedly suppressed ventricular preexcitation. Subsequent mapping
at the posterolateral TA reproducibly resulted in catheter-induced mechan-
ical block of AP conduction and RF current delivered at this site abolished
the AP In the other pt, RF delivered at the posterolateral TA successfully
interrupted AP conduction. Conclusion: These data suggest that APs with
Mahaim-like preexcitation may occasionally run parallel to the TA for some
cm before penetrating into the ventricle.
The determinants of atrioventricular (AV) nodal "slow pathway" conduction
remain controversial. We hypothesized that anterograde "slow pathway"
conduction time depends on the length (rather than functional properties)
of the pathway. Therefore, we studied 19 patients (4 men and 15 women,
mean age 51 ± 4 years) with typical AV nodal reentrant tachycardia (AVNRT)
who underwent successful radiofrequency ablation (RFA) of the "slow path-
way". As a measure of the pathway length we determined two distances in
both RAO and LAO projections: I) coronary sinus (CS) os to the His bundle
and 2) mapping catheter tip at the successful ablation site to the His bun-
dle. These distances were correlated with the conduction time of the "slow
pathway" (AH interval) during programmed atrial stimulation following cou-
pling intervals longer than the functional "slow pathway" refractory period
and during AVNRT. RFA was initially attempted in the posteroseptal area of
the right atrium close to the CS os and was delivered at progressively supe-
rior and anterior locations (closer to the compact AV node) only when inferior
RFA applications were unsuccessful.
Results: There was a significant correlation between the anterograde
"slow pathway" conduction time (AH) and the distance between the map-
ping catheter tip (MAP) and the His bundle (HIS) in both LAO (Fig.) and RAO
projections (p < 0.001). This was true when slow pathway conduction time
was measured either during programmed atrial stimulation or during AVNRT.
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"Slow pathway" conduction time did not correlate with tie distance be-
tween the CS os and the His bundle.
Conclusion: In this study, AV nodal "slow pathway" conduction time was
related to the distance between the "slow pathway" atrial insertion site and
the His Bundle. This supports the hypothesis that "slow pathway" conduc-
tion time is in part due to pathway length and may not be due to functional
properties.
